CHARMACYPHAR：ANNOUNCEMENTOFANNUALRESULTSFORTHEYEARENDED31DECEMBER2018.pdf

《CHARMACYPHAR：ANNOUNCEMENTOFANNUALRESULTSFORTHEYEARENDED31DECEMBER2018.pdf》由会员分享，可在线阅读，更多相关《CHARMACYPHAR：ANNOUNCEMENTOFANNUALRESULTSFORTHEYEARENDED31DECEMBER2018.pdf（25页珍藏版）》请在三个皮匠报告上搜索。

1、 1 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited(the“Stock Exchange”)take no responsibility for the contents of this announcement,make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever ar

2、ising from or in reliance upon the whole or any part of the contents of this announcement.CHARMACY PHARMACEUTICAL CO.,LTD.創美藥業股份有限公司(a joint stock limited liability company established in the People s Republic of China)(Stock Code:2289)ANNOUNCEMENT OF ANNUAL RESULTSFOR THE YEAR ENDED 31 DECEMBER 201

3、8FINANCIAL SUMMARY In 2018,the operating revenue of the Group was RMB3,935.25 million,decreasing by 3.92%as compared to RMB4,095.84 million in 2017.In 2018,the net profit of the Group amounted to RMB44.76 million,representing an increase of 1.05%compared with RMB44.29 million in 2017.In 2018,the Gro

4、ups net profit attributable to the shareholders of parent company was RMB45.43 million,increased by 1.50%as compared to RMB44.76 million in 2017.In 2018,the Groups basic and diluted earnings per share was RMB0.42 as compared to RMB0.41 in 2017.The Board recommends the distribution of a final dividen

5、d of RMB0.30 per share(tax inclusive)for the year ended 31 December 2018.ANNUAL RESULTSThe board(the“Board”)of directors(the“Directors”)of Charmacy Pharmaceutical Co.,Ltd.(the“Company”or“we”)is pleased to announce the audited consolidated financial results of the Company and its subsidiaries(the“Gro

6、up”)for the year ended 31 December 2018,together with the comparative figures for the year ended 31 December 2017.2 CONSOLIDATED INCOME STATEMENTFor the year ended 31 December 201820182017NotesRMBRMBI.Total operating revenue 3,935,245,977.18 4,095,835,450.18Including:operating revenue4 3,935,245,977